4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-26-004080
EVP & Chief Financial Officer acquired 4,600 shares (option exercise)
- EVP & Chief Financial Officer gave up 928 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Schorno Dean L · EVP & Chief Financial Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-01 | Shares withheld for taxes : show line 1 in the form | −928 | $47.50 | $44,080 | 78,362 | D |
| 2026-09-02 | Exercise or conversion : show line 2 in the form | +694 | $12.70 | $8,814 | 79,056 | D |
| 2026-09-02 | Exercise or conversion : show line 3 in the form | +620 | $18.70 | $11,594 | 79,676 | D |
| 2026-09-02 | Exercise or conversion : show line 4 in the form | +2,000 | $24.20 | $48,400 | 81,676 | D |
| 2026-09-02 | Exercise or conversion : show line 5 in the form | +1,286 | $24.20 | $31,121 | 82,962 | D |
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-02 | Exercise or conversion : show line 6 in the form Employee Stock Option (right to buy) | −694 | 12,824 | D |
| 2026-09-02 | Exercise or conversion : show line 7 in the form Employee Stock Option (right to buy) | −620 | 9,012 | D |
| 2026-09-02 | Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) | −2,000 | 7,999 | D |
| 2026-09-02 | Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) | −1,286 | 15,867 | D |
Loading xslF345X06/form4.xml…